In this study, phyto-compounds from aqueous extract of Costus spicatus rhizome were investigated for their inhibitory activities against PEPCK, α-amylase, β-glucosidase, and fructose-1,6-bisphosphatase in silico as potential novel therapeutic targets for insulin resistance treatment associated with PCOS. This evidence concerns the gene PCK2 and polycystic ovary syndrome.